cache/735faaebebaf4346582a76b1ba7d3e2f07f7499a5cbba62d37c43c9a1f5f0e89

COM:SANTEN

Santen Pharmaceutical Co., Ltd

  • Stock

Last Close

1,666.50

21/11 06:45

Market Cap

650.87B

Beta: -

Volume Today

1.24M

Avg: -

  • locale

    jpJapan
  • market

    STOCKS
  • industry

    Pharmaceuticals
  • website

    www.santen.com
  • ipo date

    Jan 04, 2001

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is...Show More

peer of

competitor of